Tennessee 114th General Assembly Status: Enacted 2 R cosponsors

HB 0491 — AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.

Last action — Comp. became Pub. Ch. 302

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 09, 2025. Enacted.

Signed by Governor Bill Lee (Republican) on April 21, 2025.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 74% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 2 sponsors

    1 primary, 1 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 R).

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Bill Text

Action History

  1. Filed for introduction

  2. Introduced, Passed on First Consideration

  3. Passed on Second Consideration, refer to Senate Judiciary Committee

  4. Placed on Senate Judiciary Committee calendar for 3/4/2025

  5. Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays0 PNV 0

  6. Placed on Senate Regular Calendar for 3/10/2025

  7. Senate adopted Amendment (Amendment 1 - SA0041)

  8. Passed Senate as amended, Ayes 29, Nays 0, PNV 1

  9. Engrossed; ready for transmission to House

  10. Rcvd. from S., held on H. desk.

  11. Subst. for comp. HB.

  12. Am. withdrawn. (Amendment 1 - HA0377)

  13. Passed H., Ayes 91, Nays 0, PNV 1

  14. Enrolled and ready for signatures

  15. Signed by Senate Speaker

  16. Signed by H. Speaker

  17. Transmitted to Governor for action.

  18. Signed by Governor.

  19. Pub. Ch. 302

  20. Effective date(s) 05/02/2025

  21. Filed for introduction

  22. Intro., P1C.

  23. P2C, ref. to Judiciary Committee

  24. Assigned to s/c Civil Justice Subcommittee

  25. Placed on s/c cal Civil Justice Subcommittee for 3/5/2025

  26. Rec for pass if am by s/c ref. to Judiciary Committee

  27. Placed on cal. Judiciary Committee for 3/12/2025

  28. Action def. in Judiciary Committee to 3/19/2025

  29. Placed on cal. Judiciary Committee for 3/19/2025

  30. Action def. in Judiciary Committee to 3/26/2025

  31. Placed on cal. Judiciary Committee for 3/26/2025

  32. Action def. in Judiciary Committee to 4/02/2025

  33. Placed on cal. Judiciary Committee for 4/2/2025

  34. Action def. in Judiciary Committee to 4/9/2025

  35. Placed on cal. Judiciary Committee for 4/9/2025

  36. Rec. for pass. if am., ref. to Finance, Ways, and Means Committee

  37. Assigned to s/c Finance, Ways, and Means Subcommittee

  38. Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/14/2025

  39. Rec. for pass by s/c ref. to Finance, Ways, and Means Committee

  40. Placed on cal. Finance, Ways, and Means Committee for 4/15/2025

  41. Rec. for pass; ref to Calendar & Rules Committee

  42. Placed on cal. Calendar & Rules Committee for 4/15/2025

  43. H. Placed on Regular Calendar for 4/16/2025

  44. Comp. SB subst.

  45. Sponsor(s) Added.

  46. Comp. became Pub. Ch. 302

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 131 not signed on

Sponsors (1)

Co-sponsors (1)

Not signed on (131)

131 members have not signed on to this bill.

Show all 131 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

public-safety healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 0491 do?
Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Who sponsors HB 0491?
HB 0491 is sponsored by Farmer, Andrew (Republican) and Powers, Dennis (Republican).
What is the current status of HB 0491?
This bill has been enacted into law. Introduced January 09, 2025. Enacted.
Where can I track HB 0491?
Track HB 0491 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 0491

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 0491

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →